NCT03093844View on ClinicalTrials.gov

Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

November 27, 2024

Study Completion Date

February 5, 2025

Conditions
Hematologic Disorders
Interventions
DEVICE

Miltenyi CliniMACS® CD34 Reagent System

Miltenyi CliniMACS® CD34 Reagent System will be used to prepare CD34+ enriched/T-cell depleted cells from haploidentical mobilized peripheral blood.

Trial Locations (1)

80045

University of Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03093844 - Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders | Biotech Hunter | Biotech Hunter